EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Electronic cigarettes for smoking cessation: An overview of systematic reviews and evidence and gap map

Angela Difeng Wu iD, Monserrat Conde iD, Ailsa R Butler iD, Ethan Knight, Nicola Lindson iD, Jonathan Livingstone-Banks iD, Peter Hajek iD, Hayden McRobbie iD, Rachna Begh, Annika Theodoulou iD, Caitlin Notley iD, Tari Turner und 2 weitere

Addiction · 2026-08 · 121 (8) · 1957-1971

DOI: 10.1111/add.70388 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Addiction, online erschienen am 26.03.2026. Verfasst von Angela Difeng Wu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Smoking Cessation, Electronic Nicotine Delivery Systems. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Electronic cigarettes (EC) are considered a smoking cessation tool in some countries, such as the United Kingdom, but uncertainty remains internationally over whether their benefits outweigh potential harms when used for this purpose. This overview (1) synthesised existing evidence from systematic reviews (SR) on the effectiveness and safety of ECs to explore and address these uncertainties and disagreements and (2) mapped primary intervention studies to identify priorities for further research.

Methods

Overview of SRs published from 1 January 2015 and meeting the inclusion criteria of the Cochrane review of EC for smoking cessation. We searched seven databases to April 2024. We followed Cochrane screening and data extraction methods. We adapted Campbell Collaboration and 3ie methods for the Evidence and Gap Map (EGM). We assessed review quality using AMSTAR‐2.

Results

We included 14 reviews of intervention studies (7 high quality; 7 low quality), with search dates from 2014 to 2023, in adult populations including the general population, people at risk of lung cancer, with comorbid health conditions and pregnant people. Eighteen studies were included across multiple reviews, some of which included multiple meta‐analyses. Across 21 meta‐analytic comparisons of nicotine EC versus other interventions, all reported point estimates favouring nicotine EC for smoking cessation, with relative risks/odds ratios typically in the range 1.17–1.67 versus nicotine replacement therapy and 1.46–2.09 versus non‐nicotine EC, with higher‐quality reviews giving more consistent estimates. Of 13 reviews that meta‐analysed serious adverse events (SAEs), two reported point estimates suggesting increased SAEs with nicotine EC; other estimates included the possibility of no difference. For adverse events, pooled estimates generally indicated little or no difference between groups. Our EGM mapped 90 primary, complete studies and identified absolute gaps in evidence comparing the effects of nicotine EC to cytisine, bupropion and nicotine pouches. Most studies used collected data from high‐income countries.

Conclusion

Meta‐analyses of electronic cigarettes (EC) for smoking cessation report point estimates favouring higher ≥6‐month smoking cessation rates with nicotine EC compared with nicotine replacement therapy, non‐nicotine EC/placebo, behavioural or no support and mixed support. Evidence on serious adverse events (SAEs) remains inconclusive. Evidence gaps were identified in SAE data and in studies from low‐ and middle‐income countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smoking CessationElectronic Nicotine Delivery SystemsHumansEvidence GapsSystematic Reviews as TopicNicotine Replacement Therapy

Stichwörter der Autor:innen

electronic cigarettesevidence and gap mapevidence synthesisoverview of reviewsmokingsmoking cessationtobaccovapes

Autor:innen und Institutionen

  • Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
  • Norwich Medical School, University of East Anglia, Norwich, UK.
  • Cochrane Australia, School of Public Health & Preventive Medicine, Melbourne, Australia.
  • Department of Health Promotion and Policy, University of Massachusetts, Amherst, MA, USA.

ORCID-Profile: Angela Difeng Wu, Monserrat Conde, Ailsa R Butler, Nicola Lindson, Jonathan Livingstone-Banks, Peter Hajek, Hayden McRobbie, Annika Theodoulou, Caitlin Notley, Jamie Hartmann-Boyce

Förderung

  • Cancer Research UK

Zitieren

APA

Wu, A. D., Conde, M., Butler, A. R., Knight, E., Lindson, N., Livingstone-Banks, J., Hajek, P., McRobbie, H., Begh, R., Theodoulou, A., Notley, C., Turner, T., Zhitnik, E., & Hartmann-Boyce, J. (2026). Electronic cigarettes for smoking cessation: An overview of systematic reviews and evidence and gap map. Addiction, 121(8), 1957-1971. https://doi.org/10.1111/add.70388

Vancouver

Wu AD, Conde M, Butler AR, Knight E, Lindson N, Livingstone-Banks J, et al. Electronic cigarettes for smoking cessation: An overview of systematic reviews and evidence and gap map. Addiction. 2026;121(8):1957-1971. doi:10.1111/add.70388

BibTeX
@article{Wu2026,
  author = {Wu, Angela Difeng and Conde, Monserrat and Butler, Ailsa R and Knight, Ethan and Lindson, Nicola and Livingstone-Banks, Jonathan and Hajek, Peter and McRobbie, Hayden and Begh, Rachna and Theodoulou, Annika and Notley, Caitlin and Turner, Tari and Zhitnik, Eliza and Hartmann-Boyce, Jamie},
  title = {Electronic cigarettes for smoking cessation: An overview of systematic reviews and evidence and gap map},
  journal = {Addiction},
  year = {2026},
  volume = {121},
  number = {8},
  pages = {1957--1971},
  doi = {10.1111/add.70388}
}
Kostenlos starten →